Ovarian hyperstimulation syndrome (OHSS) is a potentially serious complication that can occur during fertility treatment, particularly in women undergoing ovarian stimulation for assisted reproductive technologies such as in vitro fertilization (IVF) or ovulation induction for intrauterine insemination (IUI). OHSS is characterized by enlargement of the ovaries and accumulation of fluid in the abdominal cavity and other body tissues due to exaggerated response to fertility medications.
While mild cases of OHSS may cause discomfort and bloating, severe OHSS can lead to complications such as ovarian torsion, ascites, pleural effusion, thromboembolism, and renal failure. Prevention, early recognition, and appropriate management of OHSS are essential to minimize risks and optimize outcomes for affected individuals.